Revised SPC: Verzenios (abemaciclib) Film-coated Tablets

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
30 October 2019

Abstract

SPC has been updated to advise that in the event of elevation in AST and/or ALT to >3 x upper limit of normal (ULN) with total bilirubin >2 x ULN, in the absence of cholestasis, abemaciclib should be discontinued.